Laura DeCastro

2.4k total citations
24 papers, 1.0k citations indexed

About

Laura DeCastro is a scholar working on Genetics, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Laura DeCastro has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 13 papers in Hematology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Laura DeCastro's work include Hemoglobinopathies and Related Disorders (23 papers), Iron Metabolism and Disorders (10 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Laura DeCastro is often cited by papers focused on Hemoglobinopathies and Related Disorders (23 papers), Iron Metabolism and Disorders (10 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Laura DeCastro collaborates with scholars based in United States, United Kingdom and Canada. Laura DeCastro's co-authors include Kenneth I. Ataga, Myron A. Waclawiw, William F. McCarthy, Samir K. Ballas, Martin H. Steinberg, Oswaldo Castro, Wally R. Smith, Paul Swerdlow, Abdullah Kutlar and Mary Wood and has published in prestigious journals such as Blood, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Laura DeCastro

24 papers receiving 995 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura DeCastro United States 11 848 661 221 80 71 24 1.0k
Yih‐Ming Yang United States 13 544 0.6× 422 0.6× 175 0.8× 68 0.8× 16 0.2× 22 693
Raphael Fraser United States 16 243 0.3× 308 0.5× 167 0.8× 103 1.3× 23 0.3× 42 707
Sachith Mettananda Sri Lanka 14 427 0.5× 362 0.5× 142 0.6× 168 2.1× 14 0.2× 77 820
Benedetta Contoli Italy 11 258 0.3× 205 0.3× 116 0.5× 104 1.3× 47 0.7× 31 756
Ifeyinwa Osunkwo United States 19 637 0.8× 469 0.7× 326 1.5× 82 1.0× 10 0.1× 29 1.0k
Anne Yardumian United Kingdom 13 393 0.5× 278 0.4× 138 0.6× 37 0.5× 16 0.2× 22 684
Louise Dorn United States 9 444 0.5× 322 0.5× 315 1.4× 303 3.8× 15 0.2× 12 770
Ellen Butensky United States 12 368 0.4× 343 0.5× 78 0.4× 49 0.6× 6 0.1× 18 783
Marlene Peters‐Lawrence United States 11 208 0.2× 144 0.2× 79 0.4× 26 0.3× 18 0.3× 12 425
Abdulmohsen Al-Swailem Saudi Arabia 8 149 0.2× 107 0.2× 72 0.3× 60 0.8× 15 0.2× 13 633

Countries citing papers authored by Laura DeCastro

Since Specialization
Citations

This map shows the geographic impact of Laura DeCastro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura DeCastro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura DeCastro more than expected).

Fields of papers citing papers by Laura DeCastro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura DeCastro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura DeCastro. The network helps show where Laura DeCastro may publish in the future.

Co-authorship network of co-authors of Laura DeCastro

This figure shows the co-authorship network connecting the top 25 collaborators of Laura DeCastro. A scholar is included among the top collaborators of Laura DeCastro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura DeCastro. Laura DeCastro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Philips, Brian J., Mehdi Nouraie, Laura DeCastro, et al.. (2024). Higher Hemoglobin Level Correlates with Increased Tissue Oxygenation in a Comprehensive Profile of Hemorheology in Sickle Cell Disease. Blood. 144(Supplement 1). 294–294. 1 indexed citations
2.
Andemariam, Biree, Henny H. Billett, William B. Ershler, et al.. (2023). Real-World Experience of Individuals with Sickle Cell Disease Treated with Voxelotor: Initial Report from the Multicenter, Prospective Prospect Study. Blood. 142(Supplement 1). 2499–2499. 2 indexed citations
3.
DeCastro, Laura, et al.. (2023). Predicting Hemoglobin Response to Hydroxyurea and Voxelotor in Adults with Sickle Cell Disease. Blood. 142(Supplement 1). 3895–3895. 1 indexed citations
4.
5.
Jonassaint, Charles R., et al.. (2022). Prevalence of Substance Use Disorders in Sickle Cell Disease Compared to Other Chronic Conditions: a Population-Based Study of Black American Adults. Journal of General Internal Medicine. 38(5). 1214–1223. 7 indexed citations
6.
Liem, Robert I., Sophie Lanzkron, Thomas D. Coates, et al.. (2019). American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease. Blood Advances. 3(23). 3867–3897. 95 indexed citations
7.
Walker, Aisha L., Rosta Farzan, Laura M. Gaydos, Laura DeCastro, & Charles R. Jonassaint. (2016). Assessing Perceptions of Hydroxyurea Among Sickle Cell Disease Stakeholders Using Social Media. Blood. 128(22). 318–318. 1 indexed citations
8.
Wun, Ted, Lori Styles, Laura DeCastro, et al.. (2014). Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia. PLoS ONE. 9(7). e101301–e101301. 52 indexed citations
9.
Klings, Elizabeth S., Roberto F. Machado, Robyn J. Barst, et al.. (2014). An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease. American Journal of Respiratory and Critical Care Medicine. 189(6). 727–740. 155 indexed citations
10.
Magnani, John L., Frans A. Kuypers, John T. Patton, et al.. (2012). Pan-Selectin Antagonist GMI-1070 Affects Biomarkers of Adhesion, Activation and the Coagulation Cascade in Sickle Cell Adults At Steady State. Blood. 120(21). 87–87. 1 indexed citations
11.
Edwards, Christopher L., Cindy Swinkels, Mary Wood, et al.. (2012). Sleep and Chronic Pain in an Ethnically Congruent Sample of Adult Patients with Sickle Cell Disease (SCD). 5 indexed citations
12.
Tanabe, Paula, et al.. (2011). Evaluation of a Train-the-Trainer Workshop on Sickle Cell Disease for ED Providers. Journal of Emergency Nursing. 39(6). 539–546. 14 indexed citations
13.
Stanton, Michael, Charles R. Jonassaint, Christopher L. Edwards, et al.. (2010). The Association of Optimism and Perceived Discrimination With Health Care Utilization in Adults With Sickle Cell Disease. Journal of the National Medical Association. 102(11). 1056–1064. 22 indexed citations
14.
Steinberg, Martin H., William F. McCarthy, Oswaldo Castro, et al.. (2010). The risks and benefits of long‐term use of hydroxyurea in sickle cell anemia: A 17.5 year follow‐up. American Journal of Hematology. 85(6). 403–408. 353 indexed citations
15.
Kamble, Shital, Shelby D. Reed, Charlene Flahiff, Soheir Adam, & Laura DeCastro. (2010). Resource Use and Expenditures Among Adult Sickle Cell Patients with and without Depression. Blood. 116(21). 1534–1534. 3 indexed citations
16.
Ballas, Samir K., William F. McCarthy, Nan Guo, et al.. (2009). Exposure to Hydroxyurea and Pregnancy Outcomes in Patients With Sickle Cell Anemia. Journal of the National Medical Association. 101(10). 1046–1051. 89 indexed citations
17.
Edwards, Christopher L., Mary Wood, Miriam Feliu, et al.. (2009). Depression, Suicidal Ideation, and Attempts in Black Patients With Sickle Cell Disease. Journal of the National Medical Association. 101(11). 1090–1095. 39 indexed citations
18.
Villers, Margaret S., Margaret G. Jamison, Leo R. Brancazio, Laura DeCastro, & Allison James. (2006). Morbidity associated with sickle cell disease in pregnancy. American Journal of Obstetrics and Gynecology. 195(6). S106–S106. 5 indexed citations
19.
Harrison, Myleme O., Christopher L. Edwards, Harold G. Koenig, et al.. (2005). Religiosity/Spirituality and Pain in Patients With Sickle Cell Disease. The Journal of Nervous and Mental Disease. 193(4). 250–257. 101 indexed citations
20.
Ataga, Kenneth I., et al.. (2004). Efficacy and Safety of the Gardos Channel Inhibitor, ICA-17043, in Patients with Sickle Cell Anemia.. Blood. 104(11). 103–103. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yih‐Ming Yang Breakdown of academic impact, for papers by Raphael Fraser Breakdown of academic impact, for papers by Sachith Mettananda Breakdown of academic impact, for papers by Benedetta Contoli Breakdown of academic impact, for papers by Ifeyinwa Osunkwo Breakdown of academic impact, for papers by Anne Yardumian Breakdown of academic impact, for papers by Louise Dorn Breakdown of academic impact, for papers by Ellen Butensky Breakdown of academic impact, for papers by Marlene Peters‐Lawrence Breakdown of academic impact, for papers by Abdulmohsen Al-Swailem
Rankless by CCL
2026